UNSPSC 51433933: Elgodipine hydrochloride

This classification denotes a calcium channel blocker with the molecular formula C29H33FN2O6.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MIR106H7SI, chemically known as 2-((p-fluorobenzyl)methylamino)ethyl isopropyl (+/-)- 1,4-dihydro-2,6-dimethyl-4-(2,3-(methylenedioxy)phenyl)-3,5-pyridinedicarboxylate hydrochloride, but more generally known as elgodipine hydrochloride, which bears US NIH Compound Identifier 60701.

European Medicines Agency schedules elgodipine hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06484MIG. Most nations, for tariff purposes, schedule elgodipine hydrochloride under HS 29349990. SMILES: CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2CCCC3C2OCO3)C(=O)OCCN(C)CC4CCC(CC4)F.CL.

UNSPSC 51433933 Elgodipine hydrochloride, a Commodity code, covers pharmaceutical active ingredients and finished medications procured by state and local health and emergency services agencies. Recent state and local activity under this code reflects procurement of advanced life support medications — emergency pharmaceuticals stocked and administered by fire rescue and emergency medical services departments. The City of Tampa's Fire Rescue department represents the primary buying profile: municipal fire and rescue agencies solicit sealed bids for critical medications including vasopressors, cardiac agents, and other drugs specified by quantity, potency, and expiration-date requirements. Suppliers must meet exacting product-quality standards, including warranty against defects, replacement obligations for expired stock before nine-month windows close, and comprehensive safety documentation under OSHA Hazard Communication Standards. Delivery timelines are compressed — ten calendar days from order receipt — and pricing must be firm and fully inclusive of freight and taxes.

The City of Tampa posted the most recent relevant opportunity on April 24, 2026, under Solicitation 26P00188 for Advanced Life Support Medications, a sealed-bid IFB with a response deadline of April 8, 2026 and an estimated contract value of $40,000.00. Tampa's procurement was sheltered under a Small Local Business Enterprise (SLBE) set-aside with a 5 percent bid discount for eligible participants, capped at $10,000. The contract includes a one-year base term with two one-year renewal options and three 30-day unilateral extension periods. Geographic activity appears concentrated in Florida; the source does not support recent opportunities in other states or multiple issuing bodies under this code.